Noelle K. LoConte, MD close
Noelle K. LoConte, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Noelle K. LoConte, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. LoConte is an associate professor of medicine at the University of Wisconsin. She completed medical school at the University of Illinois at Chicago, then did her internship in internal medicine at UW. Dr. LoConte completed her internal medicine residency at Oregon Health Sciences University in Portland. She has also completed fellowship training in both medical oncology as well as geriatrics. She joined the faculty of the UW Carbone Cancer Center in the summer of 2006. She is the recipient of the American Society of Clinical Oncology Young Investigator Award for 2006, and has funding from the Centers for Disease Control and the National Cancer Institute.  She has been a principal investigator on many clinical trials of new chemotherapies for gastrointestinal cancers, from Phase I through Phase III studies.  Dr. LoConte is also the co-leader of the UW Carbone Cancer Center gastrointestinal disease oriented working group. Dr. LoConte's clinical interests are in gastrointestinal cancers, including liver and pancreas cancers, as well as cancer of any type in the older adult.



UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
University Hospital
(608) 263-7502 | (800) 323-8942 | Map
University Hospital
(608) 263-7502 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Medical Oncology
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency Oregon Health and Science University Hospital, Portland, OR
Internship University of Wisconsin Hospital and Clinics, Madison, WI

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. LoConte's research interests are in predictors of chemotherapy toxicity, as well as trials of chemotherapy in older adults and patients with gastrointestinal cancers.

PubMed Articles
Smith SM Wachter K Burris HA 3rd Schilsky RL George DJ Peterson DE Johnson ML Markham MJ Mileham KF Beg MS Bendell JC Dreicer R Keedy VL Kimple RJ Knoll MA LoConte N MacKay H Meisel JL Moynihan TJ Mulrooney DA Mulvey TM Odenike O Pennell NA Reeder-Hayes K Smith C Sullivan RJ Uzzo R Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. J Clin Oncol . 2021 Apr 1;39(10):1165-1184
[PubMed ID: 33527845]
Tevaarwerk AJ Kwekkeboom K Buhr KA Dennee A Conkright W Onitilo AA Robinson E Ahuja H Kwong RW Nanad R Wiegmann DA Chen K LoConte NK Wisinski KB Sesto ME Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study. Cancer . 2021 Mar 1;127(5):801-808
[PubMed ID: 33231882]
Hutcherson BA Cordoba S LoConte NK Edgoose JYC When We Become 'We'. WMJ . 2021 Mar;120(S1):S78-S79
[PubMed ID: 33819410]
Kaiksow FA Merss KB LoConte N An Epidemiological Crossroads: The Intersection of Incarceration and Health Care. WMJ . 2021 Mar;120(S1):S10-S12
[PubMed ID: 33819396]
Witt JS Kuczmarska-Haas A Lubner M Reeder SB Cho SY Minter R Weber S Ronnekleiv-Kelly S Abbott D LoConte N Mulkerin DL Lubner SJ Uboha NV Deming D Ritter MA Mohindra P Bassetti MF A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys . 2021 Feb 1;109(2):458-463
[PubMed ID: 32942002]
Hewitt DB Nissen N Hatoum H Musher B Seng J Coveler AL Al-Rajabi R Yeo CJ Leiby B Banks J Balducci L Vaccaro G LoConte N George TJ Brenner W Elquza E Vahanian N Rossi G Kennedy E Link C Lavu H A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer. Ann Surg . 2020 Dec 22;
[PubMed ID: 33630475]
Puckett Y Wilke L Weber S Parkes A LoConte NK Low Rate of SARS-CoV-2 Infection in Adults With Active Cancer Diagnosis in a Nonendemic Region in the United States. WMJ . 2020 Dec;119(4):286-288
[PubMed ID: 33428842]
Murphy AG Zahurak M Shah M Weekes CD Hansen A Siu LL Spreafico A LoConte N Anders NM Miles T Rudek MA Doyle LA Nelkin B Maitra A Azad NS ETCTN-9231 Study Team. A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. Clin Transl Sci . 2020 Nov;13(6):1178-1188
[PubMed ID: 32738099]
Kratz JD LoConte NK Defining Early Multidisciplinary Goals: NEXTO Trial in High-Risk Colorectal Cancer with Liver Metastases. Ann Surg Oncol . 2020 Oct;27(11):4075-4078
[PubMed ID: 32444912]
Uboha NV Lubner SJ LoConte NK Mulkerin DL Eickhoff JC Deming DA Phase 1 dose escalation trial of TAS-102 (trifluridine/tipiracil) and temozolomide in the treatment of advanced neuroendocrine tumors. Invest New Drugs . 2020 Oct;38(5):1520-1525
[PubMed ID: 32253554]
Nachtigal E LoConte NK Kerch S Zhang X Parkes A Variation in Breast Cancer Screening Recommendations by Primary Care Providers Surveyed in Wisconsin. J Gen Intern Med . 2020 Sep;35(9):2553-2559
[PubMed ID: 32495085]
Alberg AJ LoConte NK Foxhall L Weinstock MA Gomez SL Francisco M Moushey EA Gershenwald JE American Society of Clinical Oncology Policy Statement on Skin Cancer Prevention. JCO Oncol Pract . 2020 Aug;16(8):490-499
[PubMed ID: 32374709]
Schmuhl NB Mooney KE Zhang X Cooney LG Conway JH LoConte NK No association between HPV vaccination and infertility in U.S. females 18-33 years old. Vaccine . 2020 May 19;38(24):4038-4043
[PubMed ID: 32253100]
Markham MJ Wachter K Agarwal N Bertagnolli MM Chang SM Dale W Diefenbach CSM Rodriguez-Galindo C George DJ Gilligan TD Harvey RD Johnson ML Kimple RJ Knoll MA LoConte N Maki RG Meisel JL Meyerhardt JA Pennell NA Rocque GB Sabel MS Schilsky RL Schneider BJ Tap WD Uzzo RG Westin SN Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol . 2020 Apr 1;38(10):1081
[PubMed ID: 32013670]
Hwang JP LoConte NK Rice JP Foxhall LE Sturgis EM Merrill JK Torres HA Bailey HH Oncologic Implications of Chronic Hepatitis C Virus Infection. J Oncol Pract . 2019 Dec;15(12):629-637
[PubMed ID: 31825756]
Denu RA Maloney J Tomasallo CD Jacobs NM Krebsbach JK Schmaling AL Perez E Bersch AJ LeCaire TJ Meiman JG Malecki KM LoConte NK Survey of Radon Testing and Mitigation by Wisconsin Residents, Landlords, and School Districts. WMJ . 2019 Dec;118(4):169-176
[PubMed ID: 31978285]
Le DT Picozzi VJ Ko AH Wainberg ZA Kindler H Wang-Gillam A Oberstein P Morse MA Zeh HJ 3rd Weekes C Reid T Borazanci E Crocenzi T LoConte NK Musher B Laheru D Murphy A Whiting C Nair N Enstrom A Ferber S Brockstedt DG Jaffee EM Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study). Clin Cancer Res . 2019 Sep 15;25(18):5493-5502
[PubMed ID: 31126960]
Hu ZI Bendell JC Bullock A LoConte NK Hatoum H Ritch P Hool H Leach JW Sanchez J Sohal DPS Strickler J Patel R Wang-Gillam A Firdaus I Yu KH Kapoun AM Holmgren E Zhou L Dupont J Picozzi V Sahai V O'Reilly EM A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer. Cancer Med . 2019 Sep;8(11):5148-5157
[PubMed ID: 31347292]
Guerard EJ Harmon GE Sahasrabudhe KD LoConte NK Recent advances in non-surgical management of cancer in the elderly. F1000Res . 2018;7
[PubMed ID: 30505429]
Engle JA Traynor AM Campbell TC Wisinski KB LoConte N Liu G Wilding G Kolesar JM Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center. J Oncol Pharm Pract . 2018 Jul;24(5):348-353
[PubMed ID: 28457192]